top of page
A L T I T U D E
Life Science Ventures
HOME
ABOUT
PORTFOLIO
Fund IV
Fund III
Fund II
Historical
TEAM
NEWS
CONTACT
More
Use tab to navigate through the menu items.
Companies in the News
eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company
Common stock and warrants expected to commence trading on Nasdaq on August 26, 2021 under the ticker symbols EFTR and EFTRW SAN DIEGO,...
Aug 25, 2021
BiotechBayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Sometimes, it takes $1.5 billion to make "one plus one equal three." Bayer wanted to "really transform" its R&D engine under its recently...
Aug 5, 2021
bottom of page
